SLC6A4 and depressive symptom measurement: For clinical depression state assessment in the independent test cohort across all subjects, SLC6A4, increased in expression in low mood, had an AUC of 61% (p = 1.1E−02) if measured cross-sectionally, and AUC of 66% (p = 1.78E−02) if measured longitudinally.